Physician profile
Chalak Berzingi
NPI 1225073711
$14,084.10
in general payments reported to CMS, 2019-2025
19 companies · $2,512 in 2025
The $2,512 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,054 · 2020: $268 · 2021: $180 · 2022: $3,321 · 2023: $367 · 2024: $1,382 · 2025: $2,512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,174 · Travel and Lodging: $2,087.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,174.38 |
| Travel and Lodging | $2,086.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,322.74 | 2019-2025 | Coroflow, Dragonfly Opstar, Xience Skypoint |
| Boston Scientific Corporation | $2,151.29 | 2019-2025 | Avvigo Guidance System |
| Abiomed | $2,044.19 | 2019-2024 | Impella |
| Edwards Lifesciences Corporation | $1,611.66 | 2019 | |
| Teleflex LLC | $1,467.88 | 2023-2025 | Guideliner, Turnpike |
| Penumbra, INC. | $966.29 | 2022-2024 | Indigo System |
| Cardiovascular Systems INC. | $662.23 | 2019-2021 | |
| Philips North America LLC | $545.02 | 2022-2025 | Azurion 7 B20, Azurion 7 M20, Coronary Other |
| Shockwave Medical, INC | $386.70 | 2025 | |
| Medtronic Vascular, INC. | $244.14 | 2019-2020 | |
| Inari Medical, INC. | $129.79 | 2022 | |
| Asahi Intecc USA, INC. | $124.55 | 2021-2022 | |
| Medtronic, INC. | $115.00 | 2025 | Onyx Frontier |
| Bayer Healthcare Pharmaceuticals INC. | $103.53 | 2023 | |
| Arrow International, INC. | $91.68 | 2023 | Turnpike |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $59.05 | 2019-2020 | |
| Livanova USA, INC. | $27.32 | 2019 | |
| Biotronik INC. | $16.26 | 2021 | |
| Terumo Medical Corporation | $14.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chalak Berzingi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.